Home > Healthcare > Healthcare IT > Payer/Provider Solutions > Clinical Trial Imaging Market

Clinical Trial Imaging Market Size

  • Report ID: GMI7394
  • Published Date: Nov 2023
  • Report Format: PDF

A PHP Error was encountered

Severity: Warning

Message: getimagesize(linical Trial Imaging Market Size</h2> <p>Clinical Trial Imaging Market size was around USD 1.1 billion in 2022 and is expected to reach USD 2.4 billion by 2032 due to the increasing demand for novel products to treat chronic disorders. upsurge in R&amp;D investment and activities, increasing number of clinical trials. For instance, according to ClinicalTrials.gov 2023, there are 452,604 clinical trials registered worldwide, with 64,838 actively recruiting participants. This marks a substantial increase from the approximately 365,000 trials recorded in 2021.<br width=): failed to open stream: No such file or directory

Filename: v2_reports/body1.php

Line Number: 256

Backtrace:

File: /home/admin/web/gminsights.com/public_html/application/views/v2_reports/body1.php
Line: 256
Function: getimagesize

File: /home/admin/web/gminsights.com/public_html/application/views/v2_layouts/master_header_footer.php
Line: 1098
Function: view

File: /home/admin/web/gminsights.com/public_html/application/controllers/Reports.php
Line: 667
Function: view

File: /home/admin/web/gminsights.com/public_html/index.php
Line: 305
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: getimagesize(linical Trial Imaging Market Size</h2> <p>Clinical Trial Imaging Market size was around USD 1.1 billion in 2022 and is expected to reach USD 2.4 billion by 2032 due to the increasing demand for novel products to treat chronic disorders. upsurge in R&amp;D investment and activities, increasing number of clinical trials. For instance, according to ClinicalTrials.gov 2023, there are 452,604 clinical trials registered worldwide, with 64,838 actively recruiting participants. This marks a substantial increase from the approximately 365,000 trials recorded in 2021.<br width=): failed to open stream: No such file or directory

Filename: v2_reports/body1.php

Line Number: 256

Backtrace:

File: /home/admin/web/gminsights.com/public_html/application/views/v2_reports/body1.php
Line: 256
Function: getimagesize

File: /home/admin/web/gminsights.com/public_html/application/views/v2_layouts/master_header_footer.php
Line: 1098
Function: view

File: /home/admin/web/gminsights.com/public_html/application/controllers/Reports.php
Line: 667
Function: view

File: /home/admin/web/gminsights.com/public_html/index.php
Line: 305
Function: require_once

Clinical Trial Imaging Market Size

Clinical Trial Imaging Market size was around USD 1.1 billion in 2022 and is expected to reach USD 2.4 billion by 2032 due to the increasing demand for novel products to treat chronic disorders. upsurge in R&D investment and activities, increasing number of clinical trials. For instance, according to ClinicalTrials.gov 2023, there are 452,604 clinical trials registered worldwide, with 64,838 actively recruiting participants. This marks a substantial increase from the approximately 365,000 trials recorded in 2021.

To understand key trends  
Download Free Sample
 

 

Clinical Trial Imaging Market

To understand market opportunities  
Download Free Sample
 

Clinical trial imaging is the process of using advanced medical imaging techniques, such as MRI, CT scans, PET scans, and X-rays, to evaluate the effectiveness and safety of new medical treatments, drugs, or medical devices. It involves the acquisition, analysis, and interpretation of medical images to assess the impact of a treatment on a patient's condition. Clinical trial imaging is crucial in drug development, allowing researchers to visualize disease progression, treatment responses, and potential side effects, aiding in the development of new healthcare solutions.
 

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size for clinical trial imaging was around USD 1.1 billion in 2022 and is expected to reach USD 2.4 billion by end of 2032, owing to the increasing demand for novel products to treat chronic disorders.

The magnetic resonance imaging (MRI) segment is expected to reach USD 649.7 million by the end of 2032 as it helps researchers and clinicians track changes in tumor size, assess the impact of treatment regimens, and monitor safety concerns during clinical trials.

North America market share was 40.3% in 2022 and will grow substantially through 2032, owing to the region's growing number of clinical trials, a strong focus on healthcare innovation, and the presence of leading pharmaceutical and biotech companies.

ICON PLC, Medidata, WCG Clinical, Radiant Sage, Biomedical Systems Corporation, Biotelemetry, Inc., Image Core Lab, WCG Clinical, Ixico PLC, Medspace Holdings Inc., Resonance Health Limited Median Technologies, WorldCare Clinical, and Navitas Clinical Research, Inc.

Clinical Trial Imaging Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 290
  • Countries covered: 21
  • Pages: 170
 Download Free Sample